Trial Profile
Evaluation of IMVAMUNE Smallpox Vaccine With Respect to Safety and Optimization of Immune Responses by Different Vaccination Regimens in Vaccinia-Naive Adults.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 20 Nov 2013
Price :
$35
*
At a glance
- Drugs Smallpox vaccine (Primary)
- Indications Smallpox
- Focus Adverse reactions; Pharmacodynamics
- 09 May 2013 Results published in Vaccine.
- 16 Mar 2010 Actual patient number (226) added as reported by ClinicalTrials.gov.
- 20 May 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.